264 related articles for article (PubMed ID: 12377770)
81. The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase.
Lim S; Zou Y; Friedman E
J Biol Chem; 2002 Dec; 277(51):49438-45. PubMed ID: 12384504
[TBL] [Abstract][Full Text] [Related]
82. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
Kayali AG; Austin DA; Webster NJ
Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
[TBL] [Abstract][Full Text] [Related]
83. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
84. Activation of p38 MAP-kinase and caldesmon phosphorylation are essential for urokinase-induced human smooth muscle cell migration.
Goncharova EA; Vorotnikov AV; Gracheva EO; Wang CL; Panettieri RA; Stepanova VV; Tkachuk VA
Biol Chem; 2002 Jan; 383(1):115-26. PubMed ID: 11930938
[TBL] [Abstract][Full Text] [Related]
85. IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes.
Wery-Zennaro S; Zugaza JL; Letourneur M; Bertoglio J; Pierre J
Oncogene; 2000 Mar; 19(12):1596-604. PubMed ID: 10734320
[TBL] [Abstract][Full Text] [Related]
86. Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38.
Yustein JT; Xia L; Kahlenburg JM; Robinson D; Templeton D; Kung HJ
Oncogene; 2003 Sep; 22(40):6129-41. PubMed ID: 13679851
[TBL] [Abstract][Full Text] [Related]
87. Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.
Uddin S; Ah-Kang J; Ulaszek J; Mahmud D; Wickrema A
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):147-52. PubMed ID: 14694199
[TBL] [Abstract][Full Text] [Related]
88. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
Aguirre Ghiso JA; Kovalski K; Ossowski L
J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
[TBL] [Abstract][Full Text] [Related]
89. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade.
Lasa M; Mahtani KR; Finch A; Brewer G; Saklatvala J; Clark AR
Mol Cell Biol; 2000 Jun; 20(12):4265-74. PubMed ID: 10825190
[TBL] [Abstract][Full Text] [Related]
90. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
Kumar B; Koul S; Petersen J; Khandrika L; Hwa JS; Meacham RB; Wilson S; Koul HK
Cancer Res; 2010 Jan; 70(2):832-41. PubMed ID: 20068172
[TBL] [Abstract][Full Text] [Related]
91. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
Sliva D; Rizzo MT; English D
J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
[TBL] [Abstract][Full Text] [Related]
92. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
[TBL] [Abstract][Full Text] [Related]
93. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.
Chou RH; Hsieh SC; Yu YL; Huang MH; Huang YC; Hsieh YH
PLoS One; 2013; 8(8):e71983. PubMed ID: 23940799
[TBL] [Abstract][Full Text] [Related]
94. Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.
Yoshizawa T; Hammaker D; Boyle DL; Corr M; Flavell R; Davis R; Schett G; Firestein GS
J Immunol; 2009 Jul; 183(2):1360-7. PubMed ID: 19561096
[TBL] [Abstract][Full Text] [Related]
95. p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens.
Yu R; Mandlekar S; Lei W; Fahl WE; Tan TH; Kong AN
J Biol Chem; 2000 Jan; 275(4):2322-7. PubMed ID: 10644681
[TBL] [Abstract][Full Text] [Related]
96. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.
Webb DJ; Nguyen DH; Gonias SL
J Cell Sci; 2000 Jan; 113 ( Pt 1)():123-34. PubMed ID: 10591631
[TBL] [Abstract][Full Text] [Related]
97. Effects of constitutively active and dominant negative MAPK kinase (MKK) 3 and MKK6 on the pH-responsive increase in phosphoenolpyruvate carboxykinase mRNA.
O'Hayre M; Taylor L; Andratsch M; Feifel E; Gstraunthaler G; Curthoys NP
J Biol Chem; 2006 Feb; 281(5):2982-8. PubMed ID: 16319064
[TBL] [Abstract][Full Text] [Related]
98. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
[TBL] [Abstract][Full Text] [Related]
99. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta.
Jiang Y; Gram H; Zhao M; New L; Gu J; Feng L; Di Padova F; Ulevitch RJ; Han J
J Biol Chem; 1997 Nov; 272(48):30122-8. PubMed ID: 9374491
[TBL] [Abstract][Full Text] [Related]
100. p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor.
Qi X; Tang J; Pramanik R; Schultz RM; Shirasawa S; Sasazuki T; Han J; Chen G
J Biol Chem; 2004 May; 279(21):22138-44. PubMed ID: 15037631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
